{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:05:44Z","timestamp":1793138744141,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.vaccine.2022.02.021","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T17:29:24Z","timestamp":1644514164000},"page":"1722-1740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy of commercially available vaccines against canine leptospirosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"40","author":[{"given":"Stephanie","family":"Bergmann Esteves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassia","family":"Moreira Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Ferreira Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amane","family":"Pald\u00eas Gon\u00e7ales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Gil Alves Guilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Marinelli Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitika","family":"Kuribaiashi Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Alonso Miotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2022.02.021_b0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/jsap.12328","article-title":"European consensus statement on leptospirosis in dogs and cats","volume":"56","author":"Schuller","year":"2015","journal-title":"J Small Anim Pract"},{"issue":"3-4","key":"10.1016\/j.vaccine.2022.02.021_b0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.vetmic.2014.06.015","article-title":"Pathogenesis of leptospirosis: Cellular and molecular aspects","volume":"172","author":"Adler","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2022.02.021_b0015","doi-asserted-by":"crossref","first-page":"105037","DOI":"10.1016\/j.prevetmed.2020.105037","article-title":"Meta-analysis of risk factors for canine leptospirosis","volume":"181","author":"Ricardo","year":"2020","journal-title":"Prev Vet Med"},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.021_b0020","first-page":"201","article-title":"Genotypes of Leptospira spp. strains isolated from dogs in Buenos Aires, Argentina","volume":"46","author":"Loffler","year":"2014","journal-title":"Rev Argent Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.02.021_b0025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/pathogens9060484","article-title":"Detection of New Leptospira Genotypes Infecting Symptomatic Dogs: Is a New Vaccine Formulation Needed?","volume":"9","author":"Bertasio","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2022.02.021_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-020-05211-1","article-title":"Genetic relatedness of Leptospira interrogans serogroup Autumnalis isolated from humans, dogs, and mice in Japan","volume":"13","author":"Koizumi","year":"2020","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2022.02.021_b0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2460\/javma.1991.199.03.351","article-title":"Leptospira interrogans serovar bratislava infection in two dogs","volume":"199","author":"Nielsen","year":"1991","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2022.02.021_b0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2460\/javma.1982.180.04.435","article-title":"Infections with Encephalitozoon cuniculi and Leptospira interrogans, serovars grippotyphosa and ballum, in a kennel of Foxhounds","volume":"180","author":"Cole","year":"1982","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2022.02.021_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14405\/kjvr.2020.60.1.1","article-title":"Genotyping of the causative Leptospira in symptomatic dogs in Thailand","volume":"60","author":"Paungpin","year":"2020","journal-title":"Korean J Vet Res"},{"key":"10.1016\/j.vaccine.2022.02.021_b0050","doi-asserted-by":"crossref","unstructured":"Miotto BA, Tozzi BF, Penteado M de S, Guilloux AGA, Moreno LZ, Heinemann MB, et al. Diagnosis of Acute Canine Leptospirosis Using Multiple Laboratory Tests and Characterization of the Isolated Strain. BMC Vet Res 2018;14:1\u20139. https:\/\/doi.org\/10.1186\/s12917-018-1547-4.","DOI":"10.1186\/s12917-018-1547-4"},{"issue":"7","key":"10.1016\/j.vaccine.2022.02.021_b0055","doi-asserted-by":"crossref","first-page":"e0200384","DOI":"10.1371\/journal.pone.0200384","article-title":"Prospective study of canine leptospirosis in shelter and stray dog populations: Identification of chronic carriers and different Leptospira species infecting dogs","volume":"13","author":"Miotto","year":"2018","journal-title":"PLoS ONE"},{"issue":"16","key":"10.1016\/j.vaccine.2022.02.021_b0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/vr.c4965","article-title":"Control of canine leptospirosis in Europe: time for a change?","volume":"167","author":"Ellis","year":"2010","journal-title":"Vet Rec"},{"issue":"10","key":"10.1016\/j.vaccine.2022.02.021_b0065","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.2460\/ajvr.2005.66.1780","article-title":"Serologic responses of dogs given a commercial vaccine against Leptospira interrogans serovar pomona and Leptospira kirschneri serovar grippotyphosa","volume":"66","author":"Barr","year":"2005","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.021_b0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0264-410X(00)00129-8","article-title":"Evidence of cross-protection within Leptospira interrogans in an experimental model","volume":"19","author":"Sonrier","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.021_b0075","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/jvim.12337","article-title":"Vaccine-associated Leptospira antibodies in client-owned dogs","volume":"28","author":"Martin","year":"2014","journal-title":"J Vet Intern Med"},{"issue":"1-2","key":"10.1016\/j.vaccine.2022.02.021_b0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vetmic.2008.12.021","article-title":"Onset and duration of protective immunity against clinical disease and renal carriage in dogs provided by a bi-valent inactivated leptospirosis vaccine","volume":"137","author":"Minke","year":"2009","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2022.02.021_b0085","first-page":"305","article-title":"One-Year Duration of Immunity in Dogs for Leptospira Interrogans Serovar Icterohaemorrhagiae After Vaccination","volume":"10","author":"Schreiber","year":"2012","journal-title":"Int J Appl Res Vet Med"},{"issue":"6","key":"10.1016\/j.vaccine.2022.02.021_b0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/vr.153.6.165","article-title":"Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis","volume":"153","author":"Andr\u00e9-Fontaine","year":"2003","journal-title":"Vet Rec"},{"issue":"1-2","key":"10.1016\/j.vaccine.2022.02.021_b0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vetimm.2013.08.002","article-title":"A new tetravalent canine leptospirosis vaccine provides at least 12 months immunity against infection","volume":"158","author":"Klaasen","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.02.021_b0100","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/jvim.15947","article-title":"Evaluation of changes in the epidemiology of leptospirosis in dogs after introduction of a quadrivalent antileptospiral vaccine in a highly endemic area","volume":"34","author":"Francey","year":"2020","journal-title":"J Vet Intern Med"},{"issue":"5","key":"10.1016\/j.vaccine.2022.02.021_b0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.biologicals.2013.06.005","article-title":"USDA regulatory guidelines and practices for veterinary Leptospira vaccine potency testing","volume":"41","author":"Srinivas","year":"2013","journal-title":"BIOLOGICALS"},{"issue":"1-2","key":"10.1016\/j.vaccine.2022.02.021_b0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.vetmic.2005.03.007","article-title":"Prevention of renal infection and urinary shedding in dogs by a Leptospira vaccination","volume":"108","author":"Schreiber","year":"2005","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2022.02.021_b0115","doi-asserted-by":"crossref","first-page":"109985","DOI":"10.1016\/j.vetimm.2019.109985","article-title":"A canine vaccine against Leptospira serovars Icterohaemorrhagiae, Canicola and Grippotyphosa provides cross protection against Leptospira serovar Copenhageni","volume":"219","author":"Bouvet","year":"2020","journal-title":"Vet Immunol Immunopathol"},{"issue":"31","key":"10.1016\/j.vaccine.2022.02.021_b0120","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.vaccine.2013.05.043","article-title":"Duration of immunity of a multivalent (DHPPi\/L4R) canine vaccine against four Leptospira serovars","volume":"31","author":"Wilson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.02.021_b0125","unstructured":"Coelho, W. A. S.; Vasconcellos, S. A.; Morais, Z. M. De; Ikuta, C. Y.; Gon\u00e7ales, A. P.; Souza, G. O. De; Dib, C. C.; Soto, F. R. M. Canine anti-leptospira bacterins commercialized in Brazil: a challenge made with indigenous strains of serovars Canicola and Copenhageni. Scientia Vitae, jun 2013;1:1 3-11."},{"issue":"1-2","key":"10.1016\/j.vaccine.2022.02.021_b0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-1135(03)00152-4","article-title":"Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine","volume":"95","author":"Klaasen","year":"2003","journal-title":"Vet Microbiol"},{"issue":"23","key":"10.1016\/j.vaccine.2022.02.021_b0135","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/vr.104694","article-title":"Fifteen-month duration of immunity for the serovar Grippotyphosa fraction of a tetravalent canine leptospirosis vaccine","volume":"182","author":"Grosenbaugh","year":"2018","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2022.02.021_b0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vacrep.2016.07.003","article-title":"Efficacy of a multivalent DAPPi-Lmulti canine vaccine against mortality, clinical signs, infection, bacterial excretion, renal carriage and renal lesions caused by Leptospira experimental challenges","volume":"6","author":"Bouvet","year":"2016","journal-title":"Vaccine Reports"},{"key":"10.1016\/j.vaccine.2022.02.021_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1939-1676.2010.0654.x","article-title":"2010 ACVIM Small Animal Consensus Statement on Leptospirosis: Diagnosis, Epidemiology, Treatment, and Prevention","volume":"25","author":"Sykes","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.vaccine.2022.02.021_b0150","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/jsap.13125","article-title":"Recommendations on vaccination for Latin American small animal practitioners: a report of the WSAVA Vaccination Guidelines Group","volume":"61","author":"Day","year":"2020","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.vaccine.2022.02.021_b0155","unstructured":"Higgins, Julian PT and Green S. Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training. Handbook 2011:649. www.training.cochrane.org\/handbook."},{"key":"10.1016\/j.vaccine.2022.02.021_b0160","first-page":"99","article-title":"Animal leptospirosis","volume":"387","author":"Ellis","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2022.02.021_b0165","doi-asserted-by":"crossref","unstructured":"Faine S. Leptospirosis. In: Evans A.S. BPS, editor. Bact. Infect. Humans. 3rth ed., Boston, MA, MA: Springer; 1998, p. 395\u2013420.","DOI":"10.1007\/978-1-4615-5327-4_21"},{"issue":"2","key":"10.1016\/j.vaccine.2022.02.021_b0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1128\/CMR.14.2.296-326.2001","article-title":"Leptospirosis","volume":"14","author":"Levett","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2022.02.021_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vaccine.2022.02.021_b0180","series-title":"Introduction to Meta-Analysis","year":"2009"},{"key":"10.1016\/j.vaccine.2022.02.021_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2022.02.021_b0190","unstructured":"R Core Team. RStudio: Integrated Development Environment for R. RStudio 2020."},{"key":"10.1016\/j.vaccine.2022.02.021_b0195","series-title":"Systematic Reviews in Health Care","year":"2001"},{"issue":"31","key":"10.1016\/j.vaccine.2022.02.021_b0200","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.vaccine.2013.05.041","article-title":"A new multivalent (DHPPi\/L4R) canine combination vaccine prevents infection, shedding and clinical signs following experimental challenge with four Leptospira serovars","volume":"31","author":"Wilson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.02.021_b0205","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1590\/S0100-736X2011001100011","article-title":"Kinetics of the humoral immune response of dogs young immunized with Leptospira interrogans","volume":"31","author":"Castro","year":"2011","journal-title":"Pesqui Vet Bras"},{"key":"10.1016\/j.vaccine.2022.02.021_b0210","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1590\/S0100-736X2013000500013","article-title":"Anticorpos revelados pelo teste de inibi\u00e7\u00e3o do crescimento de leptospiras in vitro (TICL) contra os sorovares Canicola, Icterohaemorrhagiae e Copenhageni em c\u00e3es adultos revacinados anualmente com vacina comercial contendo bacterinas dos sorovares Canicol","volume":"33","author":"Rodrigues","year":"2013","journal-title":"Pesqui vet bras"},{"key":"10.1016\/j.vaccine.2022.02.021_b0215","first-page":"427","article-title":"Prevention of a severe disease by a Leptospira vaccination with a multivalent vaccine","volume":"156","author":"Schreiber","year":"2005","journal-title":"Rev Med Vet (Toulouse)"},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.021_b0220","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1939-1676.2011.00852.x","article-title":"Effects of Recent Leptospira Vaccination on Whole Blood Real-Time PCR Testing in Healthy Client-Owned Dogs","volume":"26","author":"Midence","year":"2012","journal-title":"J Vet Intern Med"},{"issue":"7","key":"10.1016\/j.vaccine.2022.02.021_b0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/vr.101100","article-title":"A novel tetravalent Leptospira bacterin protects against infection and shedding following challenge in dogs","volume":"172","author":"Klaasen","year":"2013","journal-title":"Vet Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.021_b0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-017-1056-x","article-title":"Clinical, serological and echocardiographic examination of healthy field dogs before and after vaccination with a commercial tetravalent leptospirosis vaccine","volume":"13","author":"Spiri","year":"2017","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2022.02.021_b0235","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/1040638717725348","article-title":"Leptospira spp. vaccinal antibodies do not react with Borrelia burgdorferi peptides used in the AccuPlex 4","volume":"29","author":"Caress","year":"2017","journal-title":"J Vet Diagnostic Investig"},{"key":"10.1016\/j.vaccine.2022.02.021_b0240","doi-asserted-by":"crossref","first-page":"109960","DOI":"10.1016\/j.vetimm.2019.109960","article-title":"Development of antibody ELISA specific of Leptospira interrogans serovar Grippotyphosa, Canicola, and Icterohaemorrhagiae to monitor vaccine immunogenicity","volume":"219","author":"Cariou","year":"2020","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2022.02.021_b0245","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/VMRR.S59521","article-title":"Recent advances in canine leptospirosis: focus on vaccine development","volume":"6","author":"Adler","year":"2015","journal-title":"Vet Med Res Reports"},{"key":"10.1016\/j.vaccine.2022.02.021_b0250","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.3390\/ijerph110404316","article-title":"Though not reservoirs, dogs might transmit leptospira in New Caledonia","volume":"11","author":"Gay","year":"2014","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2022.02.021_b0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1179\/136485911X12899838683205","article-title":"Maximizing the chances of detecting pathogenic leptospires in mammals: the evaluation of field samples and a multi-sample-per-mammal, multi-test approach","volume":"105","author":"Tulsiani","year":"2011","journal-title":"Ann Trop Med Parasitol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.02.021_b0260","doi-asserted-by":"crossref","first-page":"e112356","DOI":"10.1371\/journal.pone.0112356","article-title":"Sensitive Real-Time PCR Detection of Pathogenic Leptospira spp. and a Comparison of Nucleic Acid Amplification Methods for the Diagnosis of Leptospirosis","volume":"9","author":"Waggoner","year":"2014","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2022.02.021_b0265","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.1128\/IAI.69.12.7550-7558.2001","article-title":"Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and \u03b3\u03b4 T lymphocytes","volume":"69","author":"Moore","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.02.021_b0270","article-title":"Anti-Leptospira immunoglobulin profiling in mice reveals strain specific IgG and persistent IgM responses associated with virulence and renal colonization","volume":"15","author":"Vernel-Pauillac","year":"2020","journal-title":"BioRxiv"},{"issue":"4","key":"10.1016\/j.vaccine.2022.02.021_b0275","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biologicals.2010.02.014","article-title":"An in vitro growth inhibition test for measuring the potency of Leptospira spp Sejroe group vaccine in buffaloes","volume":"38","author":"de Nardi J\u00fanior","year":"2010","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2022.02.021_b0280","doi-asserted-by":"crossref","first-page":"370","DOI":"10.11606\/issn.2318-3659.v50i5p370-378","article-title":"Controle da efic\u00e1cia de bacterinas antileptospirose: rela\u00e7\u00e3o entre os resultados dos testes de inibi\u00e7\u00e3o de crescimento de leptospiras in vitro com os do desafio in vivo em hamsters","volume":"50","author":"Gon\u00e7alves","year":"2013","journal-title":"Braz J Vet Res Anim Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.021_b0285","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1590\/S1517-83822008000300013","article-title":"Comparison of agglutinating and neutralizing antibodies to serovar hardjo in sows immunized with two commercial whole culture polivalent anti-leptospira bacterins","volume":"39","author":"Soto","year":"2008","journal-title":"Brazilian J Microbiol"},{"key":"10.1016\/j.vaccine.2022.02.021_b0290","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2200144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2200144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:09:14Z","timestamp":1759403354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2200144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0264410X2200144X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of commercially available vaccines against canine leptospirosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}